OTC · Drug Manufacturers - Specialty & Generic

Canntab Therapeutics Limited (CTABF) Stock

$0.00 OTC: CTABF Healthcare

Canntab Therapeutics Limited is a Canadian phytopharmaceutical firm dedicated to pioneering the research and development of sophisticated, pharmaceutical-grade cannabinoid preparations. The company manufactures various oral cannabis medications, including extended-release cannabinoid pills and pellets, rapidly acting cannabidiol formulations, multi-layered modified-release options, quick-dissolving flash-melt products, and dual-layer cannabinoid tablets.

Valuation

MetricValue
Price$0.00
Market Cap$3891
P/E Ratio0.00
P/B Ratio-0.02
P/S Ratio0.02
EPS (TTM)$-0.10
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-376.92%
ROA-133.33%
ROCE—
Gross Margin-320.09%
Operating Margin—
Net Margin—
Debt/Equity-5.91
Current Ratio0.33

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-3.0M$-3.0M$-4.0M$-4.0M
Net Profit$-2.0M$-2.0M$-3.0M$-4.0M$-4.0M
EPS$-0.11$-0.10$-0.10$-0.13$-0.10
Op Margin-9087.7%-1042.4%-1961.8%—-1419.4%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$5.0M$3.0M$6.0M$6.0M$3.0M
Total Liabilities$0$0$2.0M$4.0M$3.0M
Cash$4.0M$0$2.0M$1.0M$1.0M
Borrowings$0$0$1.0M$2.0M$2.0M

Latest News

CORRECTING and REPLACING Aurelius Systems Secures $40M Series A to Meet Growing Demand for Counter-Drone Systems Business Wire · Aug 6, 2026 Back to the future as world champion Springboks host All Blacks AFP · Aug 6, 2026 Michael Burry sends loud signal to stock market investors TheStreet · Aug 6, 2026 Braveheart Bio Announces Pricing of Upsized Initial Public Offering GlobeNewswire · Aug 6, 2026 Why AMD Stock Dropped Today Motley Fool · Aug 6, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-1.0M$-2.0M$-2.0M$-3.0M$-3.0M
Investing Cash Flow$0$2.0M$-1.0M$-1.0M$0
Financing Cash Flow$0$0$0$0$1.0M
Net Cash Flow$3.0M$0$2.0M$-1.0M$-1.0M
Free Cash Flow$-1.0M$-3.0M$-3.0M$-3.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.46
FCF Yield-53685.53%
Quick Ratio0.38
Interest Coverage-7.35
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Canntab Therapeutics Limited

Canntab Therapeutics Limited is a Canadian phytopharmaceutical firm dedicated to pioneering the research and development of sophisticated, pharmaceutical-grade cannabinoid preparations. The company manufactures various oral cannabis medications, including extended-release cannabinoid pills and pellets, rapidly acting cannabidiol formulations, multi-layered modified-release options, quick-dissolving flash-melt products, and dual-layer cannabinoid tablets. These offerings target a broad spectrum of health issues, such as sleep disturbances, post-traumatic stress disorder, social anxiety, various addictions, arthritis, chronic pain, appetite loss and pain linked to cancer therapies, and as an aid in managing dependency on opioids and other painkillers. Canntab Therapeutics Limited operates from its base in Markham, Canada.

Canntab Therapeutics Limited (CTABF) stock trades at $0.00 with a market capitalization of $3891. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of -0.02, price-to-sales of 0.02. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, Canntab Therapeutics Limited generates a return on equity (ROE) of -376.92%.

Official website: canntab.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides